The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, January 05, 2022
Pfizer Inc. and BioNTech SE announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) of a booster...
read more
Tuesday, January 04, 2022
Sorriso Pharmaceuticals, a company focused on transforming anti-inflammatory antibody therapy, announced that the company has closed on a $31 million ...
read more
Tuesday, January 04, 2022
Gilead Sciences, Inc. and Arcus Biosciences, Inc. announced the closing of Gilead’s option exercises to three programs in Arcus’s clinical-stage ...
read more
Wednesday, December 29, 2021
Sandoz has submitted a Marketing Authorization Application for a proposed biosimilar trastuzumab (150 mg, for intravenous use) developed by EirGenix, ...
read more
Tuesday, December 21, 2021
The U.S. Food and Drug Administration approved Apretude (cabotegravir extended-release injectable suspension) for use in at-risk adults and ...
read more
Tuesday, December 21, 2021
The Food and Drug Administration approved the second biosimilar insulin product, Eli Lilly’s Rezvoglar (insulin glargine-aglr). Rezvoglar (insulin ...
read more
Monday, December 20, 2021
AstraZeneca and Amgen’s Tezspire (tezepelumab-ekko) has been approved in the US for the add-on maintenance treatment of adult and paediatric patients ...
read more
Friday, December 17, 2021
Senhwa Biosciences, Inc., a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, ...
read more
Wednesday, December 15, 2021
ArisGlobal, a provider of life sciences software that automates core drug development with its end-to-end drug development technology platform ...
read more
Tuesday, December 14, 2021
Merck announced that the FDA has placed clinical holds on the investigational new drug applications (INDs) for the oral and implant formulations of ...
read more
Friday, December 10, 2021
Pfizer Inc. and BioNTech SE announced that the FDA has expanded the Emergency Use Authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-...
read more
Thursday, December 09, 2021
Octapharma USA announced the FDA has approved cutaquig® [Immune globulin, Subcutaneous (Human)-hipp, 16.5% Solution] for the treatment of pediatric ...
read more
Thursday, December 09, 2021
AstraZeneca's Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorization ...
read more
Wednesday, December 08, 2021
Shanghai Pharmaceuticals and Syntegon have signed an agreement to build a laboratory for continuous manufacturing technology in China. The cooperation...
read more
Friday, December 03, 2021
Bristol Myers Squibb announced that the FDA has accepted for priority review the supplemental Biologics License Application (sBLA) for Reblozyl® (...
read more